Andreea Ciulac Andreea Ciulac is former Chicago Tribune writer with almost a decade of reporting experience. She has a knack for deciphering complex medical reports and statistics and conveying them into engaging stories that will help executives in healthcare keep up with the digital transformations in their industry. She covers an array of topics from pharma to startups and the Illinois healthcare system.

September 27, 2018 3020 Views
The U.S. Food and Drug Administration (FDA) has lifted a partial clinical hold on  Epizyme’s tazemetostat trials, a ...